female repro disorders Flashcards

1
Q
  1. Describe the anatomy and physiology of the reproductive axis in the female.
A

GnRH-induced LH signal in the female is dynamic. LH and FSH are equal for day 1-5 of follicular phase. During mid cycle, pulse generator speeds up and LH and FSH rise. During luteal phase, progesterone slows pulse resulting in infrequent high amplitude LH pulses and lower FSH levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

which cells make estradiol vs androgens/ progesteron

A

Granulosa cells make estradiol and the luteal cells make the androgens: DHEA, androstenedione and testosterone, and also produce progesterone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why are female ovaries more sensitive to toxic effects of chemo and radiation than testis

A

Progenitor cells are already committed to the primary follicle stage at birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

functions of inhibin A and B

A

Inhibins inhibit FSH. the Inhibin A (α and ßA) is important in the luteal phase; the inhibin B (α and ßB) is active in the follicular phase of the menstrual cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Describe and apply a general approach to disorders of the hypothalamic-pituitary-ovarian axis.
A

exclude pregnancy, Rule out an elevated prolactin, Androgen levels are usually not indicated in the absence of hirsutism and/or acne, A GnRH stimulation test is not helpful except in the evaluation children with precocious puberty, Draw LH and FSH levels in the first 5 days after menses starts: normally LH=FSH at that time. TSH, cortisol, IGF-1,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hypogonadotropic hypogonadism labs

A

low LH, FSH and estradiol with amenorrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes of hypogonadotropic hypogonadism

A
  1. GnRH deficiency- Kallmans syndrome when associated with anosmia. 2. Hypothalamic amenorrhea- disorder of GnRH secretion (defects in amount or frequency) usually due to stress, exercise or poor nutrition. 3. Pituitary amenorrhea- prolactinoma, GH tumor, infiltrative dz (hemochromatosis, sarcoidosis, lymphocytic hypophysitis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

treatment of stress induced hypothalamic amenorrhea

A

no treatment is option but bone loss occurs with subtle deficits in estrogen deficiency and as early as 6 months after onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hypergonadotropic hypogonadism labs

A

High FSH and/or LH with low estradiol and amenorrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes of Hypergonadotropic hypogonadism

A
  1. Turners syndrome or gonadal dysgenesis (XO, XX/XO)- menopause before menarche. Require lifelong hormonal replacement. 2. Premature ovarian insufficiency- ovarian failure before 40. Autoimmune so look for other autoimmune dz, or srugical.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Signs/Sx of early gonadal failure

A

irregular menses without molimal symptoms (breast tenderness, bloating and cramping that are signs of an ovulatory cycle). FSH levels rise before LH levels (due to loss of inhibin); there is often a waxing and waning course

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List the causes of hyperandrogenic anovulation

A

Congenital adrenal hyperplasia, PCOS, tumors causing hirsutism, obesity induced anovulation, prolactinoma, Cushings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Attenuated congenital adrenal hyperplasia Sx, treatment

A

Hx of early pubarche, hirsutism, irregular menses. Family hx. Treatment: OCPs and spironolactone. Use to be glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Polycystic ovarian syndrome Symptoms

A

begins in adolescence with irregular menses, anovulation, hirsutism and acne. 60% of patients are overweight but all are insulin resistant, and many have acanthosis nigicans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PCOS labs

A

during day 1-5 of menstrual cycle: HIGH ratio of LH/FSH > 2.5/1, increased androgens, both testosterone (ovarian) and DHEAS (adrenal). Also, estrogen does not fluctuate throughout cycle as normally would. Low sex hormone binding globulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PCOS etiology

A

GnRH pulse generator is turned up too high. Ovulation rarely occurs and progesterone levels don’t rise as they normally would in the luteal phase. Defect in ovarian steroidogenesis. Insulin resistance

17
Q

Risks associated with PCOS

A

risk of developing endometrial cancer due to the effect of estrogen unopposed by progesterone, as well as insulin resistance causing glucose intolerance and frank diabetes, hypertension and premature cardiac disease. Also central obesity, low HDL, high triglycerides,

18
Q

PCOS treatment

A

If no pregnancy desired: OCPs with nonandrogenic progestin or cyclic progesterone. Treat hirsutism with spironolcatone. Metformin for insulin resistance. If pregnancy desired: clomiphene citrate +/- metformin, Letrozole (aromatase inhibitor). Stop spironolactone 3 months before conception

19
Q

What kinds of tumors can cause hyperandrogenic anovulation

A

ovarian: sertoli-leydig cell, hilar cell, lipoid cell. Adrenal: adrenocortical adenoma or carcinoma, virilizing T secreting tumor (rare)

20
Q

Tumors causing hirsutism- clinical course

A

Patients with virilizing tumors of the ovary (makes testosterone) or adrenal (makes DHEA-S) are distinguishable from those with PCOS by the rapid onset and pace and the severity of the clinical symptoms, i.e. male pattern balding, hair on upper chest and back and clitorromegaly

21
Q

Virilizing tumors labs

A

Testosterone levels >200 ng/dl or DHEAS levels >800 ng/dl suggest TUMOR

22
Q

Obesity induced anovulation- clinical course and cause

A

Normal puberty until they exceed their weight set point. Then cycles become irregular, acne, hirsutism. US shows cysts in ovary secondary to anovulation. Excessive activity of aromatase and 5a-reductase in fat tissue.

23
Q

Obesity induced anovulation labs

A

In early follicular phase: normal and equal LH and FSH, with mild elevations in androgens

24
Q

Treatment of female hypogonadism

A
  1. no treatment- stress induced hypothalamic amenorrhea. 2. Estrogen therapy. 3. Clomiphene citrate (Clomid). 4. Gonadotropin therapy. 5. Pulsatile GnRH.
25
Q

Use of estrogen therapy for hypogonadism

A

Birth control pills (BCPs) are used if contraception is an issue (BCP should have progestin without androgenic features if pt has acne and hirsutism). In congenital defects, low dose estrogens for 12-18 months to develop breast then add progesterone to differentiate ductules. Progesterone alone for dysfunctional uterine bleeding or hyperandrogenic anovulation if not estrogen deficient. In premature ovarian falure, estrogen and progesterone given similar to menopause therapy

26
Q

Use of clomiphene citrate for hypogonadism

A

Used if fertility is desired. It is a mixed estrogen agonist/antagonist that can augment folliculogenesis in patients in whom the GnRH pulse generator is not shut off completely. It fools the reproductive axis into thinking that there is estrogen deficiency. Gonadotropin levels, especially FSH levels rise, folliculogenesis improves and ovulation occurs.

27
Q

Clomid - when is it given and things to look for

A

Days 5-9 of menstrual cycle. Pt is monitored for anti-estrogen effects on cervical mucus and for rates of ovulation

28
Q

Use of gonadotropin therapy for hypogonadism

A

human menopausal gonadotropins (Pergonal) or recombinant FSH (Menotropin) and hCG (Profasi) are used to pharmacologically stimulate folliculogenesis and ovulation. Used for pts with hypothalamic amenorrhea who failed clomid or in prep for in vitro fertilization

29
Q

Gonadotropin therapy risks

A

hyperstimulation and multiple gestations

30
Q

Pulsatile GnRH therapy for hypogonadism

A

given to induce ovulation in women with hypothalamic amenorrhea to replace a deficient GnRH pulse generator. It requires intravenous administration with the use of a pump to successfully mimic the changes in the signal across the cycle

31
Q

Treatment of PCOS

A

Options include progesterone administration or a GnRH agonist (Lupron – given continuously it downregulates the GnRH receptors) for one month, to suppress endogenous GnRH, before Pergonal or pulsatile GnRH (by pump).insulin sensitizers such as metformin or the thiazoladinediones suppress androgens and improve ovulation rates in PCOS patients

32
Q

Treatment of premature ovarian failure

A

Oral contraceptives, cyclic E and P,donation of an egg from a relative or bank is now an option for fertility. Long-term estrogen replacement is indicated to protect bones and the cardiovascular system. Glucocorticoids possibly, FSH/LH and hCG possibly

33
Q

Benefits of hormone replacement in menopause

A
  1. Brain: Central nervous system effects of estrogens and progestins, ?cognition 2. Bone: protection against fractures. 3. Cardiovascular: yes lipids, no stroke, MI. 4. GU: urinary frequency, dysparunia 5. Mood: ??
34
Q

Risks of hormone replacement in menopause

A
  1. Cardiovascular: stroke MI, when given to women >20y pmp in combined regimen; ? primary vs secondary prevention vs risk. 2. Breast cancer: yes with daily conjugated estrogen and provera, not significant when conjugated estrogen alone. 3. Importance of dose response at different target tissues, genetic risks, formulations. 4. Additional investigation underway
35
Q

define premature menopause

A

cessation of menses before age 40

36
Q

What is polyglandular failure syndrome

A

Thyroid dz, ovarian failure, and addisons Dz (adrenal)